Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide

FEBS Journal

Volumn 277, Issue 4, 2010, Pages 1010-1022

  Rodziewicz Motowidło, Sylwia ^a   Mickiewicz, Beata ^a   Greber, Katarzyna ^b   Sikorska, Emilia ^a   Szultka, Łukasz ^b   Kamysz, Elzbieta ^a   Kamysz, Wojciech ^b  

^a UNIVERSITY OF GDA SK   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Antimicrobial peptides; IB 367; NMR; Protegrin 1 analogues; Three dimensional structure

Indexed keywords

ARGINYLGLYCYLLEUCYLCYSTEINYLTYROSYLARGINYLPROLYLARGINYLPHENYLALANYLVALYLCYSTEINYLVALYLGLYCINAMIDE; ARGINYLGLYCYLLEUCYLCYSTEINYLTYROSYLCYSTEINYLARGINYLGLYCYLARGINYLPHENYLALANYLCYSTEINYLVALYLCYSTEINYLVALYLGLYCINAMIDE; IB 367; PROTEGRIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG DESIGN; ERYTHROCYTE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; FUNGI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

FUNGI; POSIBACTERIA;

EID: 76149131309     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07544.x     Document Type: Article

References (60)

1. Toke O (2005) Antimicrobial peptides: new candidates in the fight against bacterial infections. Biopolymers 80, 717 735.
2. Hancock REW Chapple DS (1999) Peptide antibiotics. Antimicrob Agents Chemother 43, 1317 1323.
3. Cho Y, Turner JS, Dinh NN Lehrer RI (1998) Activity of protegrins against yeast-phase Candida albicans. Infect Immun 66, 2486 2493.
4. Brodgen KA, Ackermann M, McCray PB Tack BF (2003) Antimicrobial peptides in animals and their role in host defences. Int J Antimicrob Agents 22, 465 478.
5. Lai R, Liu H, Lee WH Zhang Y (2002) A novel proline rich bombesin-related peptide (PR-bombesin) from toad Bombina maxima. Peptides 23, 437 442.
6. Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA Lehrer RI (1993) Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett 327, 231 236.
7. Aumelas AA, Mangoni M, Roumestand C, Chiche L, Despaux E, Grassy G, Calas B Chavanieu A (1996) Synthesis and solution structure of the antimicrobial peptide protegrin-1. Eur J Biochem 237, 575 583.
8. Qu XD, Harwig SS, Oren A, Shafer WM Lehrer RI (1996) Susceptibility of Neisseria gonorrhoeae to protegrins. Infect Immun 64, 1240 1245.
9. Tamamura H, Murakami T, Horiuchi S, Sugihara K, Otaka A, Takada W, Ibuka T, Waki M, Yamamoto N Fujii N (1995) Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. Chem Pharm Bull 43, 853 858.
10. Zhao C, Ganz T Lehrer RI (1995) The structure of porcine protegrin genes. FEBS Lett 368, 197 202.
11. Gennaro R Zanetti M (2000) Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 55, 31 49.
12. Panyutich A, Shi J, Boutz PL, Zhao C Ganz T (1997) Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect Immunol 65, 978 985.
13. Fahrner RL, Dieckmann T, Harwig SS, Lehrer RI, Eisenberg D Feigon J (1996) Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. J Chem Biol 3, 543 550.
14. Mani R, Tang M, Wu X, Buffy JJ, Waring AJ, Sherman MA Hong M (2006) Membrane-bound dimer structure of a beta-hairpin antimicrobial peptide from rotational-echo double-resonance solid-state NMR. Biochemistry 45, 8341 8349.
15. Harwig SS, Swiderek KM, Lee TD Lehrer RI (1995) Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes. J Pept Sci 1, 207 215.
16. Chen J, Falla TJ, Liu H, Hurst MA, Fujii CA, Mosca DA, Embree JR, Loury DJ, Radel PA, Cheng Chang C et al. (2000) Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers 55, 88 98.
17. Harwig SS, Waring A, Yang HJ, Cho Y, Tan L Lehrer RI (1996) Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. Eur J Biochem 240, 352 357.
18. Lai JR, Huck BR, Weisblum B Gellman SH (2002) Design of non-cysteine-containing antimicrobial β-hairpins: structure-activity relationship studies with linear protegrin-1 analogues. Biochemistry 41, 12835 12842.
19. Tam JP, Wu C Yang JL (2000) Membranolytic selectivity of cystine-stabilized cyclic protegrins. Eur J Biochem 267, 3289 3300.
20. Ostberg N Kaznessis Y (2005) Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity. Peptides 26, 197 206.
21. Cole AM Waring AJ (2002) The role of defensins in lung biology and therapy. Am J Respir Med 1, 249 259.
22. Bellm L, Giles FJ, Redman R Yazji S (2002) Iseganan HCl: a novel antimicrobial agent. Expert Opin Investig Drugs 11, 1161 1170.
23. Toney JH (2002) Iseganan (IntraBiotics pharmaceuticals). Curr Opin Investig Drugs 3, 225 228.
24. Mosca DA, Hurst MA, So W, Viajar BS, Fuji CA Falla TJ (2000) IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob Agents Chemother 44, 1803 1808.
25. Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, D'Amato G, Simona Del Prete M, Orlando F, Kamysz W, Lukasiak J, Saba V et al. (2003) Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. Gut 52, 874 878.
26. Wilmot CM Thornton JM (1988) Analysis and prediction of the different types of beta-turn in proteins. J Mol Biol 203, 221 232.
27. Levitt M (1978) Conformational preferences of amino acids in globular proteins. Biochemistry 17, 4277 4285.
28. Haque TS, Little JC Gellman SH (1996) Stereochemical requirements for β-hairpin formation: model studies with four-residue peptides and depsipeptides. J Am Chem Soc 118, 6975 6985.
29. Haque TS Gellman SH (1997) Insights on β-hairpin stability in aqueous solution from peptides with enforced type I′ and type II′β-turns. J Am Chem Soc 119, 2303 2304.
30. Stanger HE Gellman SH (1998) Rules for antiparallel β-sheet design: d-Pro-Gly is superior to l-Asn-Gly for β-hairpin nucleation. J Am Chem Soc 120, 4236 4237.
31. Barchiesi F, Giacometti A, Cirioni O, Arzeni D, Kamysz W, Silvestri C, Licci A, Marigliano A, Della Vittoria A, Nadolski P et al. (2007) In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. J Chemother 19, 514 518. (Pubitemid 350177962)
32. Wüthrich K (1986) NMR of Proteins and Nucleic Acids. Wiley Interscience, New York.
33. Tsikaris V, Sakarellos-Daitsiotis M, Tzovaras D Sakarellos C (1996) Isomerization of the Xaa-Pro peptide bond induced by ionic interactions of arginine. Biopolymers 38, 673 682.
34. Wishart DS, Sykes BD Richards FM (1992) The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31, 1647 1651.
35. Wüthrich K, Billeter M Braun W (1984) Polypeptide secondary structure determination by nuclear magnetic-resonance observation of short proton distances. J Mol Biol 180, 715 740.
36. 1H nuclear magnetic-resonance spectra - computation of sterically allowed proton distances and statistical-analysis of proton distances in single-crystal protein conformations. J Mol Biol 155, 321 346.
37. Dyson HJ Wright PE (1991) Defining solution conformations of small linear peptides. Annu Rev Biophys Biophys Chem 20, 519 538.
38. Mangoni ME, Aumelas A, Charnet P, Roumestand C, Chiche L, Despaux E, Grassy G, Calas B Chavanieu A (1996) Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation. FEBS Lett 383, 93 98.
39. Mani R, Waring AJ Hong M (2007) Conformation, dynamics, and insertion of a noncysteine-containing protegrin-1 analogue in lipid membranes from solid-state NMR spectroscopy. Chembiochem 8, 1877 1884.
40. Dimarcq JL, Bulet P, Hetru C Hoffmann JA (1998) Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers 47, 465 477.
41. Mandard N, Bulet P, Caille A, Daffre S Vovelle F (2002) The solution structure of gomesin, an antimicrobial cysteine-rich peptide from the spider. Eur J Biochem 269, 1190 1198.
42. Ehret-Sabatier L, Loew D, Goyffon M, Fehlbaum P, Hoffmann JA, van Dorsselaer A Bulet P (1996) Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood. J Biol Chem 271, 29537 29544.
43. Smith JA Pease LG (1980) Reverse turns in peptides and proteins. CRC Crit Rev Biochem 8, 315 399.
44. Laederach A, Andreotti AH Fulton DB (2002) Solution and micelle-bound structures of tachyplesin I and its active aromatic linear derivatives. Biochemistry 41, 12359 12368.
45. Powers JP, Rozek A Hancock RE (2004) Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I. Biochim Biophys Acta 1698, 239 250.
46. Mandard N, Sy D, Maufrais C, Bonmatin JM, Bulet P, Hetru C Vovelle F (1999) Androctonin, a novel antimicrobial peptide from scorpion Androctonus australis: solution structure and molecular dynamics simulations in the presence of a lipid monolayer. J Biomol Struct Dyn 17, 367 380.
47. Muhle SA Tam JP (2001) Design of gram-negative selective antimicrobial peptides. Biochemistry 40, 5777 5785.
48. Lai JR, Epand RF, Weisblum B, Epand RM Gellman SH (2006) Roles of salt and conformation in the biological and physicochemical behavior of protegrin-1 and designed analogues: correlation of antimicrobial, hemolytic, and lipid bilayer-perturbing activities. Biochemistry 45, 15718 15730.
49. Fields GB Noble RL (1990) Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 35, 161 214.
50. Kaiser E, Colescott RL, Bossinger CD Cook PI (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem 34, 595 598.
51. Varian (2002). Nuclear Magnetic Resonance Instruments, VnmrTM Software, Revision 5.3B 1/97. Varian Inc., Palo Alto, CA.
52. Bartles C, Xia T, Billeter M, Günter P Wüthrich K (1995) The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J Biomol NMR 4, 1 10.
53. Güntert P, Braun W Wüthrich K (1991) Efficient computation of 3-dimensional protein structures in solution from nuclear-magnetic-resonance data using the program DIANA and the supporting programs CALIBA, HABAS and GLOMSA. J Mol Biol 217, 517 530.
54. Pardi A, Billeter M Wüthrich K (1984) Calibration of the angular dependence of the amide proton-C alpha proton coupling constants, 3JHN alpha, in a globular protein. Use of 3JHN alpha for identification of helical secondary structure. J Mol Biol 180, 741 751.
55. 13C nuclear magnetic resonance chemical shifts. J Am Chem Soc 113, 5490 5492.
56. Cierpicki T Otlewski J (2001) Amide proton temperature coefficients as hydrogen bond indicators in proteins. J Biomol NMR 21, 249 261.
57. Brünger AT (1992) The X-PLOR Software Manual, Version 3.1. Yale University Press, New Haven, CT.
58. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S Karplus M (1983) CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4, 187 217.
59. Powell MJD (1977) Restart procedures for conjugate gradient method. Math Prog 12, 241 254.
60. Koradi R, Billeter M Wüthrich K (1996) MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 15, 51 55.